The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary intracranial germ cell tumors in adolescents and adults: Results of an international, multicenter, retrospective cohort study.
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer
 
Clarissa K Heck
No Relationships to Disclose
 
Rega Kasim
No Relationships to Disclose
 
Christoph Alexander Seidel
No Relationships to Disclose
 
Veronika Blum
No Relationships to Disclose
 
Pia Paffenholz
Honoraria - BMS GmbH & Co. KG; Eisai; Janssen; Merck
Consulting or Advisory Role - Janssen; Merck; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
Marcus Hentrich
Consulting or Advisory Role - Amgen; BeiGene; Bristol Myers Squibb Germany; Eusa Pharma; Janssen-Cilag; Merck; Oncopeptides; Sanofi; Stemline Therapeutics
Speakers' Bureau - Amgen; Gilead Sciences; Janssen-Cilag; Recordati; Sanofi
Travel, Accommodations, Expenses - Gilead Sciences; Janssen-Cilag; Jazz Pharmaceuticals; Merck
 
Richard Cathomas
Honoraria - Astellas Pharma (Inst); Janssen-Cilag; Merck KGaA (Inst)
Consulting or Advisory Role - Accord Healthcare (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sandoz (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst)
 
Marinela Augustin
No Relationships to Disclose
 
Marco Timmer
No Relationships to Disclose
 
Christoph Schäfers
Honoraria - AstraZeneca; Janssen-Cilag
Research Funding - Bristol Myers Squibb Foundation (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Sophia Schäfer
No Relationships to Disclose
 
Semi Harrabi
No Relationships to Disclose
 
Dirk Jaeger
No Relationships to Disclose
 
Joerg Beyer
No Relationships to Disclose
 
Anja Lorch
No Relationships to Disclose
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; BMS; immunocore; Janssen Oncology; Merck Serono; MSD
Consulting or Advisory Role - immunocore; Janssen-Cilag; MSD; Pfizer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - Janssen Oncology; Merck Serono; Pfizer